Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA.
04:23am, Monday, 29'th Dec 2025
Novo Nordisk's CagriSema could be a brand new growth driver for the company. Eli Lilly's orforglipron is breaking into a new, lucrative market.
Why Eli Lilly Is the Unexpected Must-Buy Dividend Powerhouse to Own in 2026
07:29am, Sunday, 28'th Dec 2025
Dividend growth investing builds long-term wealth for retirement by focusing on companies that consistently increase payouts.
Ellsworth Advisors LLC Acquires 1,719 Shares of Eli Lilly and Company $LLY
05:52am, Sunday, 28'th Dec 2025
Ellsworth Advisors LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 66.6% during the undefined quarter, according to the company in its most recent 13F filing with the SEC.
Burney Co. Has $21.42 Million Stake in Eli Lilly and Company $LLY
05:52am, Sunday, 28'th Dec 2025
Burney Co. lowered its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 1.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Beacon Investment Advisory Services Inc. Cuts Stock Position in Eli Lilly and Company $LLY
05:05am, Sunday, 28'th Dec 2025
Beacon Investment Advisory Services Inc. cut its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 10.4% during the third quarter, according to the company in its most recent disclosure with
The Best Stocks to Invest $50,000 in Right Now
01:30pm, Saturday, 27'th Dec 2025
Amazon and Alphabet are key leaders in the AI race on top of their flagship businesses. Walmart benefits from consistent non-discretionary spending like groceries.
Eli Lilly and Company $LLY Stock Holdings Lessened by Blue Trust Inc.
06:36am, Saturday, 27'th Dec 2025
Blue Trust Inc. lessened its stake in shares of Eli Lilly and Company (NYSE: LLY) by 0.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 89,627 shares of the co
Eli Lilly and Company $LLY Shares Sold by Covea Finance
05:54am, Saturday, 27'th Dec 2025
Covea Finance trimmed its position in shares of Eli Lilly and Company (NYSE: LLY) by 9.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). T
Eli Lilly's New Drug Data Sets Up a High-Stakes 2026
11:37am, Friday, 26'th Dec 2025
Since early August, the world's most valuable pharmaceutical stock, Eli Lilly and Company NYSE: LLY, has put on a stellar performance. After tanking 14% on Aug. 7 due to poor clinical trial results, s
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree
04:10am, Friday, 26'th Dec 2025
This pharma player offers you safety and growth. The company is a leader in a market that may approach $100 billion by the end of the decade.
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?
11:45am, Thursday, 25'th Dec 2025
Eli Lilly is the clear leader in the burgeoning weight loss market. Its lineup and pipeline put it well ahead of even its closest competitor.
Market Today: Records, BP--Castrol deal, Wegovy pill OK
05:35pm, Wednesday, 24'th Dec 2025
Stock News Dow and S&P 500 close at records: The S&P 500 and Dow Jones notched fresh closing highs in a holiday-shortened session, with leadership from megacaps
First Look: GDP Surges, S&P Record; BP, Novo Nordisk in Focus
07:38am, Wednesday, 24'th Dec 2025
Stock News U.S. growth accelerates: U.S. GDP expanded at a 4.3% annualized pace in Q3, driven by consumer spending and net exports, though economists expect sof
Focus: Lilly, Novo lock horns in India's obesity drug race
08:06pm, Tuesday, 23'rd Dec 2025
Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year.
5 Big Drug Stocks That May Continue to Outperform in 2026
09:51am, Tuesday, 23'rd Dec 2025
Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.
